merlionpharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | MerLion |
| Description | Fighting life-threatening About us Finafloxacin Publications Contact Who we are Management Corporate strategy Company history Overview Xtoro™ Biodefense cUTI Press Releases Scienti |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | |
| Location |
Related Websites
| Site | Rank |
More to Explore
merlionpharma.com Valuation
|
US$6,590,283
Last updated: 2023-05-02 06:46:54
merlionpharma.com has Semrush global rank of 1,606,047. merlionpharma.com has an estimated worth of US$ 6,590,283, based on its estimated Ads revenue. merlionpharma.com receives approximately 760,418 unique visitors each day. Its web server is located in , with IP address . According to SiteAdvisor, merlionpharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$6,590,283 |
| Daily Ads Revenue | US$6,084 |
| Monthly Ads Revenue | US$182,501 |
| Yearly Ads Revenue | US$2,190,002 |
| Daily Unique Visitors | 50,695 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| merlionpharma.com. | NS | 86400 | NS Record: ns.inwx.de. |
| merlionpharma.com. | NS | 86400 | NS Record: ns2.inwx.de. |
| merlionpharma.com. | NS | 86400 | NS Record: ns3.inwx.eu. |
| merlionpharma.com. | MX | 3600 | MX Record: 20 metis.bbbm.mdc-berlin.de. |
| merlionpharma.com. | MX | 3600 | MX Record: 40 leda.bbbm.mdc-berlin.de. |
| merlionpharma.com. | MX | 3600 | MX Record: 30 thebe.bbbm.mdc-berlin.de. |
| merlionpharma.com. | MX | 3600 | MX Record: 10 mail.merlionpharma.de. |
HtmlToTextCheckTime:2023-05-02 06:46:54
| About us Finafloxacin Publications Contact Who we are Management Corporate strategy Company history Overview Xtoro™ Biodefense cUTI Press Releases Scientific publications Presentations and posters MerLion Pharmaceuticals About us Who we are Management Corporate strategy Company history Finafloxacin Overview Xtoro™ Biodefense cUTI Publications Press Releases Scientific publications Presentations and posters Contact 31.08.2022 - New Press Release 31st August 2022 MerLion Pharmaceuticals Announces Successful FDA Type C Meeting for the Systemic Application of the Antibiotic Finafloxacin Against Infections caused by Burkholderia pseudomallei (Melioidosis) All Press Releases MerLion Pharmaceuticals We are focused on the development of novel antibiotics to combat the evolving threat of bacterial infections in humans and animals. Who we are Xtoro™ Xtoro™ is the US FDA- and Health Canada-approved drug containing finafloxacin for the treatment of ear infections. Learn more Biodefense |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Sun, 24 Oct 2021 17:42:57 GMT Server: Apache Location: https://merlionpharma.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/2 200 date: Sun, 24 Oct 2021 17:42:57 GMT server: Apache content-language: en cache-control: private, no-store content-length: 34150 cache-control: max-age=0 expires: Sun, 24 Oct 2021 17:42:57 GMT x-ua-compatible: IE=edge x-content-type-options: nosniff content-type: text/html; charset=utf-8 |
merlionpharma.com Whois Information
Domain Name: MERLIONPHARMA.COM Registry Domain ID: 79771484_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.domrobot.com Registrar URL: http://www.inwx.com Updated Date: 2020-10-28T11:11:31Z Creation Date: 2001-11-15T06:07:51Z Registry Expiry Date: 2025-11-15T06:07:51Z Registrar: INWX GmbH & Co. KG Registrar IANA ID: 1420 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS.INWX.DE Name Server: NS2.INWX.DE Name Server: NS3.INWX.EU DNSSEC: unsigned >>> Last update of whois database: 2021-09-13T00:11:59Z <<< |